118 related articles for article (PubMed ID: 20690073)
1. Is hypoandrogenemia a component of metabolic syndrome in males?
Singh SK; Goyal R; Pratyush DD
Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):30-5. PubMed ID: 20690073
[TBL] [Abstract][Full Text] [Related]
2. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
3. Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.
Cikim AS; Ozbey N; Sencer E; Molvalilar S; Orhan Y
Diabetes Nutr Metab; 2004 Oct; 17(5):290-5. PubMed ID: 16295051
[TBL] [Abstract][Full Text] [Related]
4. Effect of Ramadan fasting on some indices of insulin resistance and components of the metabolic syndrome in healthy male adults.
Shariatpanahi ZV; Shariatpanahi MV; Shahbazi S; Hossaini A; Abadi A
Br J Nutr; 2008 Jul; 100(1):147-51. PubMed ID: 18053308
[TBL] [Abstract][Full Text] [Related]
5. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function in young adult males with metabolic syndrome.
Choudhury BK; Choudhury SD; Saikia UK; Sarma D
Diabetes Metab Syndr; 2013; 7(3):129-32. PubMed ID: 23953176
[TBL] [Abstract][Full Text] [Related]
8. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
Tripathy D; Shah P; Lakshmy R; Reddy KS
Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
[TBL] [Abstract][Full Text] [Related]
9. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
10. Inverse associations between muscle mass, strength, and the metabolic syndrome.
Atlantis E; Martin SA; Haren MT; Taylor AW; Wittert GA;
Metabolism; 2009 Jul; 58(7):1013-22. PubMed ID: 19394973
[TBL] [Abstract][Full Text] [Related]
11. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians.
Pei D; Kuo SW; Wu DA; Lin TY; Hseih MC; Lee CH; Hsu WL; Chen SP; Sheu WH; Li JC
Int J Clin Pract; 2005 Dec; 59(12):1408-16. PubMed ID: 16351672
[TBL] [Abstract][Full Text] [Related]
12. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
13. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
14. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
Guay AT; Traish A
Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
[TBL] [Abstract][Full Text] [Related]
15. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study.
Golden SH; Ding J; Szklo M; Schmidt MI; Duncan BB; Dobs A
Am J Epidemiol; 2004 Sep; 160(6):540-8. PubMed ID: 15353414
[TBL] [Abstract][Full Text] [Related]
16. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
17. Sex hormone-binding globulin levels and metabolic syndrome and its features in adolescents.
de Oya I; Schoppen S; Lasunción MA; Lopez-Simon L; Riestra P; de Oya M; Garcés C
Pediatr Diabetes; 2010 May; 11(3):188-94. PubMed ID: 19656319
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
19. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
Niskanen L; Laaksonen DE; Punnonen K; Mustajoki P; Kaukua J; Rissanen A
Diabetes Obes Metab; 2004 May; 6(3):208-15. PubMed ID: 15056129
[TBL] [Abstract][Full Text] [Related]
20. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
